Latest Regulatory Approval News

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Black Rock Mining has locked in A$10 million through a two-tranche placement to institutional and sophisticated investors, with a Share Purchase Plan to follow, aiming to accelerate early construction at its Mahenge Graphite Project.

Latrobe Magnesium has commenced start-up operations at its Hazelwood North Demonstration Plant following EPA licence renewal, overcoming recent weather-related supply setbacks. The company aims to begin magnesium oxide production within the week as it advances toward full commissioning.

Southern Palladium has initiated a comprehensive drilling campaign at its Bengwenyama PGM project, marking a critical step toward completing its Definitive Feasibility Study in early 2026. The program aims to refine metallurgical data and mine design while regulatory approvals edge closer.

First Graphene Limited reveals significant progress in commercialising its PureGRAPH graphene technology, highlighting expanding global partnerships and a robust sales pipeline valued over A$10 million.

My Foodie Box Limited is set to pivot from meal kits to mining by acquiring Australian gold, copper, and rare earth projects, renaming itself Tarrina Resources, and relisting on the ASX with a $5 million capital raise.

Halo Technologies Holdings Ltd has announced a renounceable pro rata rights issue aiming to raise up to $11 million at $0.024 per share, partially underwritten by Lodge Corporate Pty Ltd. The capital raise will support the company’s UK market entry, local growth, and ongoing software development.

Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.

Dundee Precious Metals has received court sanction for its recommended acquisition of Adriatic Metals, paving the way for a scheme of arrangement expected to take effect on 3 September 2025. The transaction will result in Adriatic shares being cancelled and DPM’s listing on the ASX as a foreign exempt entity.

Hartshead Resources has struck a pivotal Well Carry Agreement with RockRose Energy, securing full funding for its Phase C drilling costs while trimming its joint venture stake. The move also triggers a licence extension application amid UK regulatory delays.

InFocus Group Holdings launches a new division focused on digital assets, AI, and big data, supported by a conditional $10 million financing from Mythos Group. The move aims to accelerate innovation in gamification and blockchain ventures.